Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessMarkets

Sun Pharma climbs 5% after USFDA classifies Halol plant as 'No Action Indicated'

Halol is a crucial facility for Sun Pharma as it contributes around 15 percent of total US sales.

August 19, 2019 / 10:45 AM IST
Representative image

Representative image

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Shares of Sun Pharmaceutical Industries rallied 4.7 percent intraday on August 19 after the US health regulator classified company's Halol plant as 'No Action Indicated'.

No Action Indicated means no objectionable conditions or practices were found during the inspection (or the significance of the documented objectionable conditions found does not justify further action).

The Halol unit was inspected by US Food and Drug Administration during June 3-11, 2019 and the regulator issued four observations.

Halol is a crucial facility for Sun Pharma as it contributes around 15 percent of total US sales.

The unit was under USFDA warning letter since December 2015 and the same was lifted in 2018. The health regulator has issued Establishment Inspection Report to plant in June last year.

The stock was quoting at Rs 430.85, up Rs 16.10, or 3.88 percent on the BSE at 1022 hours IST.

Moneycontrol News
first published: Aug 19, 2019 10:45 am

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347